Production (Stage)
Cabaletta Bio, Inc.
CABA
$1.87
-$0.065-3.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.91% | -71.21% | -66.71% | -56.60% | -37.55% |
| Total Depreciation and Amortization | 24.00% | 19.99% | 9.05% | 3.71% | 9.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.44% | 93.03% | 57.71% | 41.28% | 30.94% |
| Change in Net Operating Assets | 169.31% | 1,495.05% | 68.35% | 1.30% | -49.73% |
| Cash from Operations | -46.37% | -64.75% | -65.64% | -58.63% | -40.60% |
| Capital Expenditure | -95.17% | -221.83% | -146.94% | 0.70% | 58.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 205.85% | 327.44% | 266.00% | 1,248.36% | -193.53% |
| Cash from Investing | 198.82% | 310.63% | 251.87% | 34,170.00% | -201.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.05% | -93.30% | -21.27% | -21.19% | 481.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Financing | -97.80% | -93.78% | -21.27% | -21.19% | 485.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -153.36% | -126.23% | 1.42% | -37.53% | 137.51% |